| Parameter | Details |
|---|---|
| Target | KIN17 (Gene ID: 22944), a DNA/RNA-binding protein involved in DNA repair |
| Host | Mouse monoclonal (e.g., ABIN6737221) |
| Reactivity | Human |
| Applications | Western blotting (WB) |
| Immunogen | Recombinant human KIN protein |
| Specificity | Recognizes human KIN; no cross-reactivity with TIM-1/KIM-1 or Kindlin-1 |
| Preservative | Sodium azide (toxic; requires specialized handling) |
Source: ABIN6737221 Product Datasheet
| Parameter | Details |
|---|---|
| Target | Kindlin-1 (FERMT1), an integrin adaptor protein |
| Host | Rabbit monoclonal (e.g., 22215-1-AP) |
| Reactivity | Human |
| Applications | Western blotting (WB), immunohistochemistry (IHC), immunofluorescence (IF) |
| Immunogen | Full-length Kindlin-1 protein |
| Key Use Cases | Studying cell adhesion, cancer metastasis, and immune modulation |
Source: Proteintech Kindlin-1 Antibody
Kindlin-1 (FERMT1) antibodies are pivotal in elucidating its role in cancer biology:
Tumor Growth: Kindlin-1 deletion in murine breast cancer models (e.g., Met-1 cells) delays tumor onset and reduces metastasis. Reintroduction of wild-type Kindlin-1 restores growth, while integrin-binding mutants (Kin1-AA) show no rescue, indicating integrin-independent mechanisms dominate tumor progression .
Immunosurveillance: In immune-competent mice, Kindlin-1 loss triggers tumor regression and induces immunological memory. Rechallenge experiments show no tumor growth in mice previously exposed to Kin1-NULL cells, suggesting adaptive immune responses .
Kindlin-1 modulates the tumor microenvironment:
IL-6 Regulation: Kindlin-1-deficient cells secrete elevated IL-6, which impairs regulatory T-cell (Treg) suppressive functions. Blocking IL-6 restores Treg activity, linking Kindlin-1 to immunosuppression .
PD-L1 Dynamics: Loss of Kindlin-1 increases PD-L1 protein on dendritic cells (DCs) but reduces Cd274 (PD-L1) gene expression in immune cells. This dual effect may promote cross-priming of anti-tumor T-cells while limiting checkpoint inhibition .
Therapeutic Targets: Kindlin-1 inhibition may enhance anti-tumor immunity by reducing Treg infiltration and IL-6-driven immunosuppression.
Biomarker Potential: Kindlin-1 expression correlates with CD274 (PD-L1) in human breast cancer datasets, suggesting co-targeting strategies .
Methodological Challenges: Sodium azide in KIN17 antibodies requires caution in handling .
KIN1 is a protein kinase that plays crucial roles in multiple cellular processes. In Schizosaccharomyces pombe (fission yeast), KIN1 has a dynamic cell-cycle regulated distribution and contributes to cytokinesis at the geometric cell center. KIN1-GFP localizes at cell tips during interphase, appearing as dynamic dots close to the plasma membrane. During mitosis, KIN1 appears as a ring overlying the cell equator prior to nuclei separation at anaphase B onset. After mitosis, KIN1 is detected at the septum synthesis site and plasma membrane invagination, suggesting its involvement in septum formation . The protein is particularly important for maintenance of cell polarity and proper cell division, as deletion mutants (kin1Δ) exhibit cell wall defects, asymmetry of division, and inhibition of cell separation .
KIN1 exhibits a highly dynamic pattern of expression and localization that changes throughout the cell cycle. In early G2 cells, KIN1-GFP is detected predominantly at the new cell end. As cells progress through G2, the signal appears at both cell ends. During mitosis, KIN1-GFP relocates to form a ring at the division site. This ring formation occurs prior to nuclei separation at anaphase B onset, coinciding with actomyosin ring (CAR) assembly. The KIN1 signal persists at cell ends during mitosis but gradually disappears at mitotic exit. Following mitosis, KIN1-GFP is detected at the septum synthesis site, then distributes on both sides of the septal structure, consistent with its localization at new cell ends in early G2 . This pattern indicates that KIN1 may play distinct roles in different phases of the cell cycle.
Based on available research, Schizosaccharomyces pombe (fission yeast) represents the primary model organism for studying KIN1 function using antibody-based approaches. This model is particularly valuable because mutants lacking KIN1 (kin1Δ) remain viable but exhibit distinct phenotypes, allowing researchers to investigate KIN1's role in cellular processes. Additionally, S. pombe permits the generation of tagged KIN1 versions (such as KIN1-GFP) that maintain wild-type functionality while enabling visualization of the protein's dynamic localization throughout the cell cycle . When designing KIN1 antibody experiments, researchers should consider whether their questions pertain to fundamental cellular processes or organism-specific functions.
For effective KIN1 detection, Western blot analysis using a specific anti-KIN1 antibody represents a standard approach for analyzing expression levels. When designing Western blot experiments, it's important to include appropriate controls, such as comparing endogenous KIN1 levels (wild-type) with conditional expression systems (ON/OFF conditions) or deletion mutants (kin1Δ) . For visualization of KIN1 localization, fluorescently tagged fusion proteins (KIN1-GFP) have proven effective for both static imaging and time-lapse video microscopy. When using KIN1-GFP, it's essential to verify that the fusion protein maintains native functionality to ensure physiologically relevant observations . For co-localization studies, combining KIN1-GFP with other tagged proteins (such as Pxl1-RFP) can provide insights into KIN1's interactions with other cellular components and its role in structures like the contractile actomyosin ring .
To investigate KIN1 function with precise temporal control, researchers can implement repressible expression systems. A recommended approach involves using the thiamine-dependent repressible promoter nmt81 to control kin1 expression (nmt81-controlled kin1). This method allows researchers to modulate KIN1 expression levels by adding or removing thiamine from the growth medium, thereby creating ON/OFF conditions. For proper experimental design, it's crucial to validate that promoter expression in the activated condition (ON) approximates endogenous KIN1 levels, while the repressed condition (OFF) results in significantly reduced protein levels . When implementing this system, researchers should verify expression levels via Western blot analysis using anti-KIN1 antibody. This approach is particularly valuable for studying phenotypes that result from KIN1 down-regulation rather than complete deletion, potentially revealing functions that might be masked in adaptation to deletion mutants .
Rigorous validation of KIN1 antibody specificity is essential for reliable experimental outcomes. Multiple complementary approaches should be employed, including: (1) Western blot comparison between wild-type cells and kin1Δ mutants to confirm absence of signal in deletion strains; (2) comparison of signal between different expression conditions using repressible promoter systems to demonstrate signal correlation with expected expression levels; (3) immunofluorescence studies comparing antibody staining patterns with the localization of fluorescently tagged KIN1 (e.g., KIN1-GFP) . For developing highly specific antibodies, computational approaches that model different binding modes can help design antibodies that discriminate between similar epitopes . When working with commercial antibodies, researchers should review validation data and independently verify specificity in their experimental system before conducting extensive studies.
Investigating KIN1 interactions in multiprotein complexes requires sophisticated experimental approaches. One effective strategy is to combine immunoprecipitation with mass spectrometry analysis to identify proteins that co-precipitate with KIN1. To distinguish direct binding partners from indirect associations, researchers can implement yeast two-hybrid screens or in vitro binding assays with purified proteins. For studying interactions in the context of specific cellular structures (such as the actomyosin ring), co-localization studies using differentially tagged proteins (e.g., KIN1-GFP with Pxl1-RFP) can provide spatial and temporal information about potential interactions . When designing co-immunoprecipitation experiments, it's important to optimize extraction conditions to preserve native protein complexes while minimizing non-specific binding. Cross-validation of interactions using multiple experimental approaches increases confidence in identified binding partners.
Developing antibodies with tailored specificity profiles for KIN1 can be approached through computational modeling integrated with experimental selection methods. This approach allows researchers to design antibodies that either specifically target KIN1 with high affinity or exhibit cross-specificity with structurally related proteins, depending on research needs. The process involves: (1) performing phage display experiments with antibody libraries against multiple ligands; (2) applying high-throughput sequencing to characterize selected antibodies; (3) using biophysics-informed models to identify distinct binding modes associated with specific ligands; and (4) computationally designing variants with desired specificity profiles . This methodology is particularly valuable when KIN1 shares structural similarities with other proteins and high specificity is required. The approach leverages the integration of experimental data with computational models to generate antibodies beyond those observed in initial selection experiments, expanding the repertoire of available research tools .
Implementing quantitative analysis techniques significantly enhances the interpretability and reproducibility of KIN1 antibody-based experiments. For Western blot analyses, researchers should use digital image analysis tools to quantify band intensities relative to loading controls, enabling statistical comparison across experimental conditions. In fluorescence microscopy studies, quantitative measurements of signal intensity, distribution patterns, and co-localization coefficients provide objective metrics for comparing KIN1 localization under different conditions . For time-lapse studies, tracking KIN1-GFP dynamics through automated image analysis allows precise characterization of protein movement during cell cycle progression. When analyzing genetic interaction experiments (e.g., comparing kin1Δ with other mutants), quantitative phenotypic measurements such as septation indices provide robust metrics for assessing functional relationships . Additionally, implementing standardized reporting of antibody validation results, including specificity tests and optimal working concentrations, enhances experimental reproducibility across research groups .
To investigate KIN1 function through genetic interaction studies, researchers should implement systematic approaches combining kin1Δ with mutations in functionally related genes. For example, combining kin1Δ with polarity mutants (pom1Δ, tea1Δ, tea4Δ) has revealed synthetic interactions affecting cytokinesis . When designing such experiments, researchers should: (1) select candidate genes based on known cellular pathways or preliminary screens; (2) generate double mutants through standard genetic techniques; (3) analyze phenotypes using quantitative metrics such as growth rates, septation indices, and cell morphology measurements; and (4) implement controls including single mutants and wild-type strains . For more nuanced analysis, conditional alleles (such as nmt81-controlled kin1) can be combined with deletion mutants to study dosage-dependent genetic interactions. This approach has revealed that Kin1 down-regulation in tea1Δ and tea4Δ backgrounds primarily impacts cytokinesis rather than cell polarity control . Fluorescence microscopy with appropriate staining techniques (e.g., for septal material) provides detailed phenotypic characterization of genetic interactions.
When studying KIN1's role in cell division processes, several complementary phenotypic assays provide comprehensive functional information. These include: (1) Septation analysis – examining the position, structure, and frequency of septa formation using fluorescence microscopy with cell wall stains; (2) Growth rate measurements – comparing colony formation on agar plates to quantify the severity of division defects; (3) Cell shape analysis – monitoring changes in cell morphology, which often correlate with division abnormalities; and (4) Cytoskeletal dynamics – tracking F-actin and microtubule organization during cell division . For detailed analysis of cytokinesis, researchers should examine contractile actomyosin ring (CAR) formation and dynamics using tagged components like Pxl1-RFP. Quantitative metrics such as septation index (percentage of cells with septa) and the frequency of abnormal septal structures provide objective measures for comparing different genetic backgrounds. Time-lapse microscopy of KIN1-GFP expressing cells can reveal the precise timing of KIN1 recruitment relative to other cytokinesis events .
KIN1 plays a critical role in ensuring proper spatial positioning of the division site. In Schizosaccharomyces pombe, cytokinesis normally occurs at the geometric cell center, a position defined by the interphase nucleus and the anillin-related Mid1 protein. Genetic evidence indicates that KIN1 functions in parallel with the polarity factors Pom1, Tea1, and Tea4 to regulate division site positioning . When KIN1 is down-regulated in pom1Δ, tea1Δ, or tea4Δ backgrounds, cells exhibit severe defects in actomyosin ring formation and septum synthesis, often resulting in misplaced or aberrant septal structures . Mechanistically, KIN1 appears to influence nuclear positioning during interphase, which subsequently affects division plane specification. In KIN1 down-regulated cells, septa remain orthogonal to the long cell axis but are frequently positioned eccentrically . This suggests that KIN1 contributes to the mechanisms that ensure the division plane intersects the cell at its geometric center, a fundamental aspect of symmetrical cell division. The synthetic phenotypes observed when combining kin1Δ with polarity mutants indicate that multiple pathways cooperatively regulate the spatial aspects of cytokinesis .
Researchers working with KIN1 antibodies may encounter several common technical challenges. For Western blot applications, insufficient signal strength can be addressed by optimizing antibody concentration, incubation conditions, and detection methods. When signal specificity is concerning, researchers should perform additional validation using knockout/knockdown controls and peptide competition assays. For immunofluorescence applications, high background signal can be reduced by optimizing blocking conditions, increasing washing stringency, and using highly specific secondary antibodies . When studying dynamic KIN1 localization, photobleaching may limit live-cell imaging duration; this can be mitigated by using optimized imaging parameters and antifade reagents. If KIN1 antibodies cross-react with related proteins, computational approaches for designing highly specific antibodies can be considered . For all applications, it's essential to determine optimal antibody concentrations through titration experiments and to include appropriate positive and negative controls in each experiment.
KIN1's involvement in multiple cellular processes presents a significant challenge for researchers attempting to isolate specific functions. To address this, several experimental strategies can be implemented: (1) Using conditional alleles (such as nmt81-controlled kin1) to avoid adaptive responses that might occur in deletion mutants; (2) Conducting time-resolved studies to distinguish primary effects from secondary consequences; (3) Combining genetic approaches with specific inhibitors of related pathways to identify functional dependencies; and (4) Creating separation-of-function mutants that affect specific domains of KIN1 . Additionally, researchers can employ rapid protein degradation systems to achieve acute KIN1 depletion at specific cell cycle stages. Complementary approaches include using structure-function analysis to identify critical residues for specific KIN1 functions and performing domain-swapping experiments to determine which regions confer functional specificity. By integrating these strategies, researchers can more effectively distinguish KIN1's direct contributions to individual cellular processes from its broader regulatory roles .